Antiproliferative substituted 5-thiapyrimidinone and
申请人:Agouron Pharmaceuticals, Inc.
公开号:US05739141A1
公开(公告)日:1998-04-14
The present invention is directed to derivatives of 5-thia- and 5-selenopyrimidinone, which are useful as inhibitors of the enzymes glycinamide ribonucleotide formyl transferase (GARFT) and amino imidazole carboxamide ribonucleotide formyl transferase AICARFT), pharmaceutical compositions containing these derivatives, and methods of using these derivatives. The present invention is also directed to intermediates useful for preparing these derivatives and methods of preparing these intermediates.
Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds
申请人:——
公开号:US20020173515A1
公开(公告)日:2002-11-21
Novel derivatives of 5-thia- and 5-selenopyrimidinone are found to inhibit the enzyme glycinamide ribonucleotide formyl transferase (GARFT) and amino imidazole carboxamide ribonucleotide formyl transferase (AICARFT). Novel intermediates of these compounds are also disclosed. A novel method of preparing such compounds is also disclosed, as well as methods and compositions for employing the compounds as antiproliferative agents.